Ekso Bionics Holdings (EKSO) Amortization of Deferred Charges (2016)
Ekso Bionics Holdings has reported Amortization of Deferred Charges over the past 4 years, most recently at -$9000.0 for Q4 2016.
- On a quarterly basis, Amortization of Deferred Charges changed 0.0% to -$9000.0 in Q4 2016 year-over-year; TTM through Dec 2016 was -$36000.0, a 2.7% increase, with the full-year FY2016 number at -$36000.0, up 2.7% from a year prior.
- Amortization of Deferred Charges reached -$9000.0 in Q4 2016 per EKSO's latest filing, roughly flat from -$9000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was -$9000.0 in Q2 2015, with the low at -$18104.0 in Q2 2013.
- The 4-year median for Amortization of Deferred Charges is -$9000.0 (2015), against an average of -$9855.0.
- Peak YoY movement for Amortization of Deferred Charges: surged 50.0% in 2014, then dropped 10.47% in 2015.
- Tracing EKSO's Amortization of Deferred Charges over 4 years: stood at -$18104.0 in 2013, then surged by 50.0% to -$9052.0 in 2014, then rose by 0.57% to -$9000.0 in 2015, then changed by 0.0% to -$9000.0 in 2016.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at -$9000.0, -$9000.0, and -$9000.0 for Q4 2016, Q3 2016, and Q2 2016 respectively.